VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
1-Year Est. Return
26.22%
1 Year Est. Return
-26.22%
AUM
$60.2M
AUM Growth
-$26.5M
(-31%)
Holding
7
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monte Rosa Therapeutics
GLUE
$621M
| $26.2M | 43.56% |
5,652,922
|
|
||
2
CRISPR Therapeutics
CRSP
$6.29B
| $17M | 28.18% |
498,558
|
|
||
|
CTNM
3
Contineum Therapeutics
CTNM
$328M
| $6.41M | 10.64% |
918,163
|
|
||
4
Skye Bioscience
SKYE
$42.8M
| $3.19M | 5.3% |
2,007,704
|
|
||
5
Repare Therapeutics
RPTX
$78.6M
| $2.61M | 4.33% |
2,646,657
|
|
||
6
Tempest Therapeutics
TPST
$45M
| $2.59M | 4.3% |
269,773
|
|
||
7
Adverum Biotechnologies
ADVM
$90M
| $2.21M | 3.68% |
506,821
|
|